La Jolla Institute for Immunology

Organisation

People

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    R35, The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer, R35CA210043, US$1.1m, 2016–2031, 4 Sept 2026

  • National Institute of Allergy and Infectious Diseases

    U01, Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging, U01AI180152, US$658.8k, 2024–2029, 9 Feb 2026

  • National Cancer Institute

    R01, Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence, R01CA279795, US$559.6k, 2024–2029, 28 Jan 2026

Sources: reporter.nih.gov